查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600976

吸入器和雾化器市场：按产品、适应症、分销类型划分 - 2025-2030 年全球预测

Inhalers & Nebulizers Market by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年吸入器和雾化器市值为93亿美元，预计2024年将达到114.5亿美元，复合年增长率为22.55%，到2030年将达到386.3亿美元。

吸入器和雾化器市场范围包括设计用于直接向肺部输送药物的设备，这对于治疗气喘、慢性阻塞性肺病（COPD）和其他肺部疾病等呼吸系统疾病至关重要。这些设备的需求源于呼吸系统疾病的日益流行以及对有效药物传输机制的需求。应用领域包括医院、诊所和家庭护理环境，最终用户范围从儿童到老年人。市场成长受到技术进步、人们对呼吸系统疾病认识的提高以及城市污染导致的与生活方式相关的呼吸系统疾病发病率上升等因素的影响。成长机会包括整合数位健康追踪的智慧吸入器技术创新以及扩大我们在医疗基础设施不断改善的新兴市场的业务。

主要市场统计
基准年[2023] 93亿美元
预测年份 [2024] 114.5亿美元
预测年份 [2030] 386.3亿美元
复合年增长率（%） 22.55%

然而，严格的法规环境、先进设备的高成本以及欠发达地区的意识低等挑战可能会阻碍成长。设备不一致和程序变化也会产生限制，这些可能会影响治疗效果。为了克服这些障碍，公司可以专注于开发轻型、便携式雾化器和具有更高准确性和患者友好介面的经济高效吸入器等领域的创新。新的研究途径包括由智慧吸入器促进的个人化医疗方法，可监测患者的依从性并提供回馈。市场参与者可以利用这些见解来增强产品差异化并获得竞争优势。策略建议包括投资研发以创建适合不同患者需求的适应性技术，并与医疗保健提供者建立伙伴关係以提供全面的服务。市场充满活力且竞争激烈，对传统和新解决方案的需求同步增长，重点是针对各种呼吸系统疾病的用户友好型和高效设计。因此，根据消费者偏好量身定制的技术进步和产品开拓是充分发挥吸入器和雾化器市场潜力的关键。

市场动态：快速发展的吸入器和雾化器市场的关键市场洞察

供需的动态交互作用正在改变吸入器和雾化器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球呼吸系统疾病盛行率不断上升
    • 雾化器和数位化改进产品的采用率增加
    • 智慧吸入器製造商与软体公司之间的数位健康伙伴关係
  • 市场限制因素
    • 智慧吸入器开发的可用性有限且成本高昂
  • 市场机会
    • 智慧吸入器设备和系统的技术进步
    • 市场主体加大投资与研发力道
  • 市场挑战
    • 与吸入器和雾化器相关的实际问题

波特五力：驾驭吸入器和雾化器市场的策略工具

波特的五力框架是了解吸入器和雾化器市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解吸入器和雾化器市场的外部影响

外部宏观环境因素在塑造吸入器和雾化器市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解吸入器/雾化器市场的竞争状况

对吸入器和雾化器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵吸入器和雾化器市场供应商的绩效评估

FPNV定位矩阵是评估吸入器和雾化器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球呼吸系统疾病发生率上升
      • 雾化器数位化产品的采用增加
      • 智慧吸入器製造商与软体公司之间的数位健康伙伴关係
    • 抑制因素
      • 智慧吸入器开发的可用性有限且高成本
    • 机会
      • 智慧吸入器设备和系统的技术进步
      • 市场参与企业增加投资和研发
    • 任务
      • 与吸入器和雾化器相关的实际问题
  • 市场区隔分析
    • 产品：广泛使用吸入器以克服呼吸系统疾病的负担
    • 适应症：消费者对气喘治疗中吸入器和雾化器的偏好不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化
    • 专利分析及趋势

第六章吸入器/雾化器市场：副产品

  • 吸入器
    • 干粉吸入器
    • 定量吸入器
  • 喷雾器
    • 喷射雾化器
    • 网状雾化器
    • 超音波雾化器

第七章依适应症分類的吸入器/雾化器市场

  • 气喘
  • 慢性阻塞性肺病

第 8 章依输送模式分類的吸入器和雾化器市场

  • 医院药房
  • 网路药房
  • 零售药房

第九章美洲吸入器和雾化器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太吸入器和雾化器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲吸入器/雾化器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 1nhaler 融资 250 万美元开发永续吸入器
    • 羽扇豆科在德国为气喘患者推出吸入器
    • 协同效应 Life Sciences推出可携式雾化器“Nebi”

公司名单

  • AMIKO Digital Health
  • United Therapeutics Corporation
  • PARI GmbH
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC
  • H&T Presspart
  • CHIESI Farmaceutici SpA
  • Omron Corporation
  • AptarGroup, Inc.
  • 3M Company
  • ICONOVO AB
  • Beximco Pharmaceuticals Ltd.
  • Koninklijke Philips NV
  • GF Health Products, Inc.
  • Narang Medical Limited
  • Mundipharma GmbH
  • Dr Trust by Nureca Ltd.
  • Sunovion Pharmaceuticals Inc.
  • Novartis AG
  • Cipla Limited
  • Merck Group
  • Vectura Group Ltd.
  • Beurer GmbH
  • Drive DeVilbiss International
  • Sensirion AG
Product Code: MRR-434CCDA05167

The Inhalers & Nebulizers Market was valued at USD 9.30 billion in 2023, expected to reach USD 11.45 billion in 2024, and is projected to grow at a CAGR of 22.55%, to USD 38.63 billion by 2030.

The scope of the Inhalers & Nebulizers market encompasses devices designed to deliver medication directly to the lungs, crucial for managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. The necessity of these devices arises from the increased prevalence of respiratory ailments and the demand for efficient drug delivery mechanisms. Application areas include hospitals, clinics, and home care settings, with end-users ranging from pediatric to geriatric patients. Market growth is influenced by factors like technological advancements, increased awareness about respiratory disorders, and the rising incidence of lifestyle-related respiratory issues due to urban pollution. Opportunities for growth include innovations in smart inhaler technology that integrates digital health tracking, and expanded market presence in developing regions with escalating healthcare infrastructure improvements.

KEY MARKET STATISTICS
Base Year [2023] USD 9.30 billion
Estimated Year [2024] USD 11.45 billion
Forecast Year [2030] USD 38.63 billion
CAGR (%) 22.55%

However, challenges such as stringent regulatory environments, high costs associated with advanced devices, and limited awareness in less developed regions can impede growth. Limitations also arise from device inconsistency and technique variability that may affect treatment efficacy. To overcome these obstacles, companies can focus on innovation in areas like lightweight, portable nebulizers, and the development of cost-effective inhalers with enhanced precision and patient-friendly interfaces. Emerging research avenues include personalized medicine approaches facilitated by smart inhalers that monitor patient adherence and provide feedback. Market players can leverage these insights to enhance product differentiation and gain a competitive edge. Strategic recommendations include investing in R&D to create adaptive technology tailored to diverse patient needs and establishing partnerships with healthcare providers for comprehensive service offerings. The market is dynamic and competitive, driven by simultaneous demand for traditional and novel solutions, with an emphasis on user-friendly, efficient designs catering to a broad spectrum of respiratory conditions. Hence, aligning product development with technological advancements and consumer preferences will be key to capturing the full potential of the inhalers and nebulizers market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalers & Nebulizers Market

The Inhalers & Nebulizers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Respiratory Diseases Globally
    • Increasing Adoption of Nebulizers and Digitally-Improved Products
    • Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
  • Market Restraints
    • Limited Availability and High Costs Associated with the Development of Smart Inhalers
  • Market Opportunities
    • Technological Advancements in Smart Inhaler Devices and Systems
    • Growing Investment and R&D by Market Players
  • Market Challenges
    • Practical Problems Associated with Inhalers & Nebulizers

Porter's Five Forces: A Strategic Tool for Navigating the Inhalers & Nebulizers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalers & Nebulizers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalers & Nebulizers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalers & Nebulizers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalers & Nebulizers Market

A detailed market share analysis in the Inhalers & Nebulizers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalers & Nebulizers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalers & Nebulizers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include AMIKO Digital Health, United Therapeutics Corporation, PARI GmbH, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, H&T Presspart, CHIESI Farmaceutici S.p.A., Omron Corporation, AptarGroup, Inc., 3M Company, ICONOVO AB, Beximco Pharmaceuticals Ltd., Koninklijke Philips N.V., GF Health Products, Inc., Narang Medical Limited, Mundipharma GmbH, Dr Trust by Nureca Ltd., Sunovion Pharmaceuticals Inc., Novartis AG, Cipla Limited, Merck Group, Vectura Group Ltd., Beurer GmbH, Drive DeVilbiss International, and Sensirion AG.

Market Segmentation & Coverage

This research report categorizes the Inhalers & Nebulizers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Inhalers and Nebulizers. The Inhalers is further studied across Dry Powder Inhalers and Metered Dose Inhalers. The Nebulizers is further studied across Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer.
  • Based on Indication, market is studied across Asthma and COPD.
  • Based on Distribution Mode, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Diseases Globally
      • 5.1.1.2. Increasing Adoption of Nebulizers and Digitally-Improved Products
      • 5.1.1.3. Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Availability and High Costs Associated with the Development of Smart Inhalers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Smart Inhaler Devices and Systems
      • 5.1.3.2. Growing Investment and R&D by Market Players
    • 5.1.4. Challenges
      • 5.1.4.1. Practical Problems Associated with Inhalers & Nebulizers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Wide availability of inhalers to overcome the respiratory disease burden
    • 5.2.2. Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Patent Analysis & Trend

6. Inhalers & Nebulizers Market, by Product

  • 6.1. Introduction
  • 6.2. Inhalers
    • 6.2.1. Dry Powder Inhalers
    • 6.2.2. Metered Dose Inhalers
  • 6.3. Nebulizers
    • 6.3.1. Jet Nebulizer
    • 6.3.2. Mesh Nebulizer
    • 6.3.3. Ultrasonic Nebulizer

7. Inhalers & Nebulizers Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD

8. Inhalers & Nebulizers Market, by Distribution Mode

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Inhalers & Nebulizers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Inhalers & Nebulizers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Inhalers & Nebulizers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler
    • 12.3.2. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
    • 12.3.3. Synergy Life Science Releases Nebi, a Portable Nebulizer

Companies Mentioned

  • 1. AMIKO Digital Health
  • 2. United Therapeutics Corporation
  • 3. PARI GmbH
  • 4. Teva Pharmaceutical Industries Ltd.
  • 5. GlaxoSmithKline PLC
  • 6. H&T Presspart
  • 7. CHIESI Farmaceutici S.p.A.
  • 8. Omron Corporation
  • 9. AptarGroup, Inc.
  • 10. 3M Company
  • 11. ICONOVO AB
  • 12. Beximco Pharmaceuticals Ltd.
  • 13. Koninklijke Philips N.V.
  • 14. GF Health Products, Inc.
  • 15. Narang Medical Limited
  • 16. Mundipharma GmbH
  • 17. Dr Trust by Nureca Ltd.
  • 18. Sunovion Pharmaceuticals Inc.
  • 19. Novartis AG
  • 20. Cipla Limited
  • 21. Merck Group
  • 22. Vectura Group Ltd.
  • 23. Beurer GmbH
  • 24. Drive DeVilbiss International
  • 25. Sensirion AG

LIST OF FIGURES

  • FIGURE 1. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALERS & NEBULIZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALERS & NEBULIZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 233. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023